Research

Our faculty member's areas of research are broad and include common allergic conditions, asthma, urticaria, autoimmunity and biotechnology, aspirin exacerbated respiratory disease, carmine allergy, atopic dermatitis, chronic sinusitis, and asthma outcomes. 

Several of our faculty conduct research at the University of Michigan Mary H. Weiser Food Allergy Center, where James R. Baker, Jr., MD, is the director. The Center's research is aimed at generating novel findings through basic and translational research that will provide future solutions for those with food allergies and can help lead to a cure for this condition.

We are a FARE (Food Allergy Research & Education) Clinical Network Center of Excellence, which is a nationwide network of leading research and clinical care facilities with a common goal of ensuring that patients with food allergies have access to state-of-the-art diagnosis, treatments, and research. 

Current Clinical Trials

• "Study to Evaluate Efficacy and Safety of Avapritinib" (BLU-285), A Selective KIT Mutation-targeted Tyrosine Kinase Inhibitor, Versus Placebo in Patients With Indolent and Smoldering Systemic Mastocytosis - Dr. Cem Akin
• "Multicenter, Open-Label, Long-Term Safety Study of AR101 Characterized Oral Desensitization Immunotherapy in Subjects who Participated in a Prior AR101 Study" - Dr. Georgiana Sanders
• Peanut Oral Immunotherapy Study of Early Intervention for Desensitization (POSEIDON)- Dr. Georgiana Sanders
• "A DOUBLE-BLIND, PLACEBO-CONTROLLED, RANDOMIZED PHASE III TRIAL TO ASSESS THE SAFETY AND EFFICACY OF VIASKIN® PEANUT IN PEANUT-ALLERGIC YOUNG CHILDREN 1-3 YEARS OF AGE" - Dr. Georgiana Sanders
• A Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Study in Pediatric Subjects with Peanut Allergy to Evaluate the Efficacy and Safety of Dupilumab as Adjunct to AR101-CODIT (Peanut Oral Immunotherapy)- Dr. Georgiana Sanders
• Observational Study of Characteristics, Treatment and Outcomes With Severe Asthma in the United States
• A Long Term Safety Study of BCX7353 in Hereditary Angioedema (APeX-S)
• “Achieving Better Control for Older Adults With Asthma". Principal Investigator: Alan Baptist, MD, MPH.
• "Long-term Safety and Efficacy Study of DX-2930 to Prevent Acute Angioedema Attacks in Patients With Type I and Type II HAE". Principal Investigator: Alan Baptist, MD, MPH.
• "Observational Study of Obstructive Lung Disease (NOVELTY)". Principal Investigator: Alan Baptist, MD, MPH.
• “Peanut Allergy Oral Immunotherapy Study of AR101 for Desensitization in Children and Adults (PALISADE)”. Principal Investigator: Georgina Sanders, MD.

Faculty Publications

• Cem Akin, MD, PhD
• Ulus Atasoy, MD
• James R. Baker, Jr., MD (Active Emeritus)
• James L. Baldwin, MD
• Alan P. Baptist, MD, MPH
• Mariel Benjamin, MD
• Jason Ellis, PhD
• Malika Gupta, MD
• Christine L. Holland, MD (Active Emeritus)
• Keerthi Karamched, MD
• Anna Kovalszki, MD
• Marc S. McMorris, MD
• Rajan Ravikumar, MD
• Georgiana M. Sanders, MD, MS
• Charles Schuler, IV, MD
• William R. Solomon, MD (Emeritus)
• Aimee L. Speck, MD